Page last updated: 2024-11-05

triazolam and Snoring

triazolam has been researched along with Snoring in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Snoring: Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, H1
Grote, L1
Peter, JH1
Cassel, W1
Guilleminault, C1

Trials

1 trial available for triazolam and Snoring

ArticleYear
The effect of triazolam and flunitrazepam--two benzodiazepines with different half-lives--on breathing during sleep.
    Chest, 1996, Volume: 109, Issue:4

    Topics: Adult; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Esophagus; Flunitrazepam; Half-

1996
chemdatabank.com